Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Multiple promising vaccines for the coronavirus are in development, Peter Marks, the director of the Food and Drug Administration’s biologics center, said during an Axios virtual event Monday.
What he's saying: Marks said the vaccine will meet the FDA's high standards of efficacy and safety, while accelerating the approval process to combat for a vaccine.
What they're saying: Marks said he hopes a vaccine would be available within nine months, rather than the usual 12-18 months the process normally takes.
- “The hope is that by working with those [promising candidates] in a way that we haven’t done things exactly the same way in the past, will move the vaccine development forward in a way that could lead to a vaccine in maybe nine months instead of the 12-18 months that people have talked about," Marks said.
Our thought bubble: Axios' Bob Herman pointed out during the event that most experts say that nine months is optimistic to develop a vaccine, because it's never happened before.
Editor's note: This story has been updated to clarify that Marks hopes, not predicts, that a vaccine will be available within nine months.